Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Published clinical trial data suggests retatrutide produces more pronounced metabolic effects than earlier-generation compounds in the populations studied
The 12mg dose produced the headline results: 24.2% mean body weight reduction at 48 weeks
Symptoms include a dark streak (black, blue, or brown line) that runs parallel with the nail, though some may have no color
Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose
Previous GLP-1 medication experience People transitioning from semaglutide or tirzepatide to retatrutide may experience different onset patterns than treatment-naive individuals
Hidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H
US$ 21.94
US$ 24.61
US$ 27.53
